N/A N=64,382

Care Coordination for Children With Disabilities

Experiences With Health Care Coordination

Bottom Line

View on ClinicalTrials.gov: NCT02304380 ↗

Enrolled (actual)

64,382

Serious AEs

0.0%

Results posted

Jun 2020

Primary outcome: Primary: Percent of Caregivers Who Reported That Their Child Has a Designated Care Coordinator — 864 Participants

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: —
Age: Pediatric, Adult, Older Adult · 3+ yrs
Sex: All
Sponsor: University of North Carolina, Chapel Hill
Primary completion: Nov 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Percent of Caregivers Who Reported That Their Child Has a Designated Care Coordinator	864	—
SECONDARY Percent of Caregivers Who Reported That Their Care Coordinator Asked About Caregiver Concerns and Changes in the Child's Health	261	—
SECONDARY Percent of Caregivers Who Reported Receiving a Comprehensive Written After-visit Summary in the Past 12 Months	523	—
SECONDARY Percent of Caregivers Who Reported That Their Child's Primary Care Provider Created a Shared Care Plan for Their Child	985	—
SECONDARY Use of One or More Well-child Visits <=6 Years Old	9,235; 25,106	—
SECONDARY Use of One or More Well-child Visits >=12 Years Old	24,342; 72,803	—
SECONDARY Indicator of Use of Primary Care	49,358; 142,579	—
SECONDARY Use of Outpatient Medicaid Visits to Other Behavioral Health Providers	49,358; 142,579	—
SECONDARY Emergency Department Use	49,358; 142,579	—
SECONDARY Use of Hospitalizations	49,358; 142,579	—
SECONDARY Follow-up Within 7 Days After Hospitalization	10,602; 31,968	—
SECONDARY Follow-up Within 30 Days After Hospitalization	10,602; 31,968	—
SECONDARY Hospital Readmissions Within 30 Days After Discharge	10,602; 31,968	—
SECONDARY Hospitalization for Mental Illness	49,358; 142,579	—
SECONDARY Follow-up Within 7 Days After Hospitalization for Mental Illness	1,484; 7,409	—
SECONDARY Follow-up Within 30 Days After Hospitalization for Mental Illness	1,484; 7,409	—
SECONDARY Medication Use - Antidepressants	49,358; 142,579	—
SECONDARY Medication Use - Anticonvulsants	49,358; 142,579	—
SECONDARY Medication Use - Anti-anxiety Medications	49,358; 142,579	—
SECONDARY Medication Use - Anti-psychotic Medications	49,358; 142,579	—
SECONDARY Medication Use - ADHD Medications	49,358; 142,579	—
SECONDARY Medication Use - Asthma Medications	49,358; 142,579	—
SECONDARY Follow-up Within 30 Days After ADHD Prescription	75,757; 214,253	—

Summary

The proposed study uses a recent policy change in Ohio as a natural experiment to assess outcomes and experiences of children who qualify for Medicaid under the Aged, Blind, Disabled category and their caregivers in an ACO model of care compared to their previous outcomes and experiences in a traditional fee-for-service model.

Eligibility Criteria

Inclusion Criteria

Stakeholder Interviews

Be associated with the ACO as ACO leadership, a care coordinator, a payor or policy-maker.

Caregiver Interviews

Currently live in south-central Ohio
Have lived in south-central Ohio since July 2012
Be a caregiver of a child ages 3-18 who qualifies for Medicaid under the Aged, Blind, and Disabled category

Focus Groups, Caregivers and Youth

Currently live in south-central Ohio
Have lived in south-central Ohio since July 2012
Be a caregiver of a child ages 3-18 who qualifies for Medicaid under the Aged, Blind, and Disabled (ABD) category, who receives care at Nationwide Children's Hospital, Partners for Kids
For youth focus groups, be a child ages 14-18 who qualifies for Medicaid under the Aged, Blind, and Disabled category, who is intellectually capable of participating in focus groups, and who receives care at Nationwide Children's Hospital, Partners for Kids

Exclusion Criteria

Non-English-speaking
For youth focus groups, intellectual disabilities that preclude being able to participate in a focus group

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02304380). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.